R&D invest 10~15% of Sales
Published: 2001-05-02 06:59:00
Updated: 2001-05-02 06:59:00
Korea Pharmaceutical Manufacturers Association (KPMA) decided to concentrate on capacities of association to secure financial resources of 10~15 percent of R&D investment and further fair competition climate, so as to improve research development abilities.
KPMA clarified that as a result of...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.